Article
The Evolutionary Origins of Recurrent Pancreatic Cancer
19 Mar 2020
Abstract excerpt
Abstract Surgery is the only curative option for stage I/II pancreatic cancer; nonetheless, most patients will experience a recurrence after surgery and die of their disease. To identify novel opportunities for management of recurrent pancreatic cancer, we performed whole-exome or targeted sequencing of 10 resected primary cancers and matched intrapancreatic recurrences or distant metastases. We identified that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
